Cargando…
Reply: Evaluating the activity of temsirolimus in neuroendocrine cancer
Autores principales: | Duran, I, Moore, M J, Siu, L L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360211/ http://dx.doi.org/10.1038/sj.bjc.6603514 |
Ejemplares similares
-
Evaluating the activity of temsirolimus in neuroendocrine cancer
por: O'Donnell, P H, et al.
Publicado: (2007) -
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
por: Duran, I, et al.
Publicado: (2006) -
Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus
por: Boni, J P, et al.
Publicado: (2008) -
Author`s Reply
por: Karaduman, Bilge Duran, et al.
Publicado: (2020) -
Evaluating new treatments for advanced cancer – reply
por: Ferguson, Jamie
Publicado: (2001)